Menlo Therapeutics Inc.·4

Jul 31, 6:33 PM ET

Kwon Paul 4

4 · Menlo Therapeutics Inc. · Filed Jul 31, 2019

Insider Transaction Report

Form 4
Period: 2019-07-29
Kwon Paul
Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2019-07-29+80,300396,812 total
    Common Stock (80,300 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
  • [F2]The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F3]Not Applicable

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION